{"id":13413,"date":"2019-06-13T08:48:43","date_gmt":"2019-06-13T12:48:43","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13413"},"modified":"2019-06-13T08:48:43","modified_gmt":"2019-06-13T12:48:43","slug":"senators-want-to-know-if-hhs-money-went-to-chinese-genomics-firms","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13413","title":{"rendered":"Senators want to know if HHS money went to Chinese genomics firms"},"content":{"rendered":"<p>(By Damian Garde for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">T<\/span>wo Republican senators are asking whether the Department of Health and Human Services might have compromised national security by indirectly doing business with genomics companies tied to China, the latest escalation in Washington\u2019s efforts to limit overseas access to American intellectual property.\u00a0 Continue reading <a href=\"https:\/\/www.statnews.com\/2019\/06\/12\/grassley-oversight-genomics-wuxi-bgi\/?utm_campaign=KHN%3A%20First%20Edition&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=73646518&amp;_hsenc=p2ANqtz-8H9G_cQX8z3hyF2TaIhkTH5dvkg6PO6LC5rtbQV2DkKFKEqIVHCrz1SJjlH6e8gPG5KKsoDdnuVcrYWhQKOtFYqtMjeA&amp;_hsmi=73646518\">article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Damian Garde for STAT) Two Republican senators are asking whether the Department of Health and Human Services might have<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,15],"tags":[],"class_list":["post-13413","post","type-post","status-publish","format-standard","hentry","category-legislative-update","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13413"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13413\/revisions"}],"predecessor-version":[{"id":13414,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13413\/revisions\/13414"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}